Development and External Validation of an Echocardiography-Based AI Model for Predicting Aortic Stenosis Progression

BACKGROUND: Aortic stenosis (AS) is the most common valvular heart disease in older adults, necessitating careful medical surveillance and timely intervention. However, current fixed surveillance intervals often fail to account for the variability of disease progression. This results in inefficient use of resources and potential delays in treatment for rapid progression of disease. OBJECTIVES: The purpose of this study was to develop and externally validate models for fixed-horizon prediction of progression from mild or moderate to severe AS. METHODS: A retrospective cohort study analyzed structured echocardiographic report data from 2 independent large tertiary centers (derivation: 9,247 visits; external validation: 3,873 visits). Three models were developed using 21 routinely available echocardiographic and demographic variables to predict progression to severe AS at 1-, 3-, and 5-year horizons. Model performance was evaluated using the area under the receiver-operating characteristic curve (AUROC) and the F1 score. RESULTS: The models demonstrated consistent discrimination across internal testing and external validation. Internal test set AUROCs were 0.90 (95% CI: 0.86-0.93), 0.91 (95% CI: 0.88-0.93), and 0.91 (95% CI: 0.87-0.95) for the 1-, 3-, and 5-year prediction horizons, respectively. External validation AUROCs were 0.91 (95% CI: 0.90-0.93), 0.88 (95% CI: 0.87-0.90), and 0.88 (95% CI: 0.87-0.90), respectively. CONCLUSIONS: Models based on routinely available structured echocardiographic data predicted progression from mild or moderate to severe AS and showed consistent performance in an independent external cohort. These findings support the potential use of structured-data risk prediction to inform personalized surveillance strategies for patients with AS.

Authors

Institutions

Publication Details

Journal
JACC Advances
Published
2026-08-14
DOI
https://doi.org/10.1016/j.jacadv.2026.103112
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and External Validation of an Echocardiography-Based AI Model for Predicting Aortic Stenosis Progression

Elad Maor, Tal Caller, Kobi Faierstein, Yuval Altman et al.
JACC Advances
Cardiac Valve Diseases and Treatments
article

Development and External Validation of an Echocardiography-Based AI Model for Predicting Aortic Stenosis Progression

Elad Maor, Tal Caller, Kobi Faierstein, Yuval Altman, Edward Itelman, Amit Segev, Leor Perl, Bar Yacobi, Ran Kornowski, Yaron Shapira
article en

Abstract

BACKGROUND: Aortic stenosis (AS) is the most common valvular heart disease in older adults, necessitating careful medical surveillance and timely intervention. However, current fixed surveillance intervals often fail to account for the variability of disease progression. This results in inefficient use of resources and potential delays in treatment for rapid progression of disease. OBJECTIVES: The purpose of this study was to develop and externally validate models for fixed-horizon prediction of progression from mild or moderate to severe AS. METHODS: A retrospective cohort study analyzed structured echocardiographic report data from 2 independent large tertiary centers (derivation: 9,247 visits; external validation: 3,873 visits). Three models were developed using 21 routinely available echocardiographic and demographic variables to predict progression to severe AS at 1-, 3-, and 5-year horizons. Model performance was evaluated using the area under the receiver-operating characteristic curve (AUROC) and the F1 score. RESULTS: The models demonstrated consistent discrimination across internal testing and external validation. Internal test set AUROCs were 0.90 (95% CI: 0.86-0.93), 0.91 (95% CI: 0.88-0.93), and 0.91 (95% CI: 0.87-0.95) for the 1-, 3-, and 5-year prediction horizons, respectively. External validation AUROCs were 0.91 (95% CI: 0.90-0.93), 0.88 (95% CI: 0.87-0.90), and 0.88 (95% CI: 0.87-0.90), respectively. CONCLUSIONS: Models based on routinely available structured echocardiographic data predicted progression from mild or moderate to severe AS and showed consistent performance in an independent external cohort. These findings support the potential use of structured-data risk prediction to inform personalized surveillance strategies for patients with AS.

JACC AdvancesVol. 5(9)
Sheba Medical Center (IL), Rabin Medical Center (IL)
Sackler Faculty of Medicine, Tel-Aviv University
Openalex Percentile: Top 9%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.